Ductal Carcinoma In Situ: Treatment Update and Current Trends

被引：0
作者：
Katrina B. Mitchell
Henry Kuerer
机构：
[1] MD Anderson Cancer Center,Breast Surgical Oncology
来源：
Current Oncology Reports | 2015年 / 17卷
关键词：
DCIS; Ductal carcinoma in situ; Clinical trials; Breast surgery; Breast-conserving therapy; Mastectomy; Contralateral mastectomy; Breast radiation; Accelerated partial breast irradiation; Breast pathology; Breast cancer therapy; Tamoxifen; Anastrozole;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Ductal carcinoma in situ (DCIS) traditionally has been managed through various combinations of surgery, radiation, and endocrine therapy. However, concern for under- or over-treatment of DCIS has led many surgeons to question historically standardized approaches and instead begin to tailor treatment based on individual prognostic indicators. Recent and ongoing clinical trials have investigated the potential for active surveillance in DCIS, the possibility of eliminating radiation therapy (RT), and ways in which adjuvant systemic therapy may be refined. This review will summarize the current trends in the treatment of DCIS, as well as highlight the most pertinent clinical trials that are shaping management today.
引用
收藏
相关论文
共 179 条
[1]  
Kuerer HM(2009)Ductal carcinoma in situ: state of the science and roadmap to advance the field J Clin Oncol 27 279-88
[2]  
Albarracin CT(2013)Cancer statistics, 2013 CA Cancer J Clin 63 11-30
[3]  
Yang WT(2010)National Institutes of Health State-of-the-Science Conference Statement: Diagnosis and Management of Ductal Carcinoma in Situ September 22–24, 2009 J Natl Cancer Inst 102 161-9
[4]  
Cardiff RD(2011)Ductal carcinoma in situ: trends in treatment over time in the US Breast Cancer Res Treat 127 251-7
[5]  
Brewster AM(2004)Ductal carcinoma in situ of the breast N Engl J Med 350 1430-41
[6]  
Symmans WF(2015)Ductal carcinoma in situ: treatment or active surveillance? Expert Rev Anticancer Ther 7 777-85
[7]  
Siegel R(2003)The University of Southern California/Van Nuys prognostic index for ductal carcinoma in situ of the breast Am J Surg 186 337-43
[8]  
Naishadham D(2013)Factors associated with decision to pursue mastectomy and breast reconstruction in the treatment of ductal carcinoma of the breast Am J Surg 206 682-5
[9]  
Jemal A(2014)Predictors that influence contralateral prophylactic mastectomy election among women with ductal carcinoma in situ who were evaluated for BRCA gene testing Ann Surg Oncol 11 3466-72
[10]  
Allegra CJ(2015)Growing use of mastectomy for ductal carcinoma in situ of the breast among young women in the United States Ann Surg Oncol 7 2378-86
12345678910